These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8797177)

  • 1. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
    Kagawa M; Nagao S; Bemana I
    J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain].
    Kagawa M; Nagao S
    No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study.
    Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H
    Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
    Bemana I; Nagao S
    Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats.
    Rosenberg GA; Scremin O; Estrada E; Kyner WT
    Stroke; 1992 Dec; 23(12):1767-73; discussion 1773-4. PubMed ID: 1448828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema.
    Bemana I; Takahashi E; Nakamura T; Kuyama H; Nagao S
    Acta Neurochir Suppl; 1997; 70():194-7. PubMed ID: 9416320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury.
    Krieg SM; Trabold R; Plesnila N
    J Neurotrauma; 2017 Apr; 34(7):1329-1336. PubMed ID: 27762660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke.
    Liu X; Nakayama S; Amiry-Moghaddam M; Ottersen OP; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):124-31. PubMed ID: 19806476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intracerebroventricular vasopressin in the development of stress-induced gastric lesions in rats.
    Büyükcoskun NI; Ozlük K
    Physiol Res; 1999; 48(6):451-5. PubMed ID: 10783910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central vasopressin blockade enhances its peripheral release in response to peripheral osmotic stimulation in conscious rats.
    Liu HW; Wang YX; Crofton JT; Funyu T; Share L
    Brain Res; 1996 May; 719(1-2):14-22. PubMed ID: 8782858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
    Trabold R; Krieg S; Schöller K; Plesnila N
    J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin-induced brain edema is mediated by the V1 receptor.
    Rosenberg GA; Estrada E; Kyner WT
    Adv Neurol; 1990; 52():149-54. PubMed ID: 2144395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
    Saad WA; Camargo LA; Antunes-Rodrigues J; Saad WA; Guarda IF; Guarda RS
    Regul Pept; 2005 Dec; 132(1-3):53-8. PubMed ID: 16198010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in centrally released arginine vasopressin by stimulation of the medullary reticular formation].
    Kuniyoshi T
    No To Shinkei; 1992 Jan; 44(1):43-8. PubMed ID: 1562384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasopressin on cold-induced brain edema in cats.
    Reeder RF; Nattie EE; North WG
    J Neurosurg; 1986 Jun; 64(6):941-50. PubMed ID: 3701445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasopressin and blood-brain barrier].
    Nagao S
    No To Shinkei; 1998 Sep; 50(9):809-15. PubMed ID: 9789303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats.
    Plesnila N; Schulz J; Stoffel M; Eriskat J; Pruneau D; Baethmann A
    J Neurotrauma; 2001 Oct; 18(10):1049-58. PubMed ID: 11686492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area.
    Mima EG; Andrade RR; Camargo LA; Saad WA
    Regul Pept; 2004 May; 118(3):159-64. PubMed ID: 15003832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septal vasopressin modulates anxiety-related behaviour in rats.
    Liebsch G; Wotjak CT; Landgraf R; Engelmann M
    Neurosci Lett; 1996 Oct; 217(2-3):101-4. PubMed ID: 8916082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.